Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 71335-2971

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 71335-2971). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
A scatter plot showing pharmacokinetic (PK) variability of venlafaxine under different special populations and analytes. It compares fold changes with 90% confidence intervals for Cmax, AUC, and ODV analytes in conditions such as hepatic and renal impairments, CYP2D6 polymorphism, age, and gender, relative to reference values.*
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
A dot plot chart showing the fold change and 90% confidence intervals for pharmacokinetic parameters (Cmax and AUC) of venlafaxine and its metabolite ODV in the presence of various interacting drugs. The x-axis represents the change relative to a reference value, with points plotted for drugs including ethanol, diazepam, cimetidine, ketoconazole, indinavir, metoprolol, imipramine, and lithium, distinguishing their effects on venlafaxine and ODV exposure.*
FDA Label Image

Figure-3 (Figure 3)

Figure-3 (Figure 3)
A dot plot chart illustrating fold change and 90% confidence intervals for pharmacokinetic parameters (Cmax and AUC) of various analytes when interacting with different drugs. The x-axis represents change relative to a reference value, with points for drugs such as diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, tolbutamide, and lithium, showing their impact on analyte concentration or exposure.*
FDA Label Image

Label (Lbl713352971)

Label (Lbl713352971)
Label for Venlafaxine Hydrochloride Extended-Release Capsules, USP 75 mg, containing 90 capsules. The product is repackaged by Bryant Ranch Prepack, Inc., Burbank, CA, and manufactured by Granules India Limited. The label includes storage instructions and a reminder to dispense a medication guide to each patient.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of venlafaxine hydrochloride showing its molecular arrangement, including a cyclohexanol, dimethylamino, and methoxyphenyl groups, alongside the hydrochloride component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.